Aidport Sp. z o.o. — Clinical Trial Site

74 Registered trials

40 Currently recruiting

Organisation

Aidport Sp. z o.o.

Location

Skorzewo, Poland

Identifier

ORG-100049010

Address

Ul Ksiedza Stanisława Kozierowskiego 24, 60-185, Poland

Departments

-
#2303 : Onkologia Kliniczna
#9004: oncology
2803 : NA
4102
AIDPORT
Aidport Sp z o o
Aidport sp z o.o.
AIDPORT Sp. z o.o.
AIDPORT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Gynaecology
Hematology
N/A
NA
nd.
Oncology
PL30003: Hematooncology
Poradnia Onkologiczna

Clinical trials at this site (74)

Search interface

Phase Ia/Ib Study of UBX-303061 in Subjects with Relapsed/Refractory B-Cell Malignancies Pending

2023-510484-35-00 B-cell malignancies 1
Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infe… Pending

2024-518420-80-00 Primary infection prophylaxis for secondary immunodefic 5
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis. Pending

2024-519298-21-00 Cancer-Associated Thrombosis (CAT). 5
A Study to Investigate Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis (KATALYST-AV) Pending

2025-522176-86-01 Moderate Calcific Aortic Valve Stenosis (CAVS) 5
A Study of Vepugratinib (LY3866288) in Participants with Cancer in the Urinary Tract ( FORAGER-2 ) Pending

2025-522855-25-00 Urinary Bladder Neoplasms 5
A study of pelabresib and ruxolitinib compared to placebo and ruxolitinib in adult patients with myelofibrosis who have not received prior t… Pending

2025-523555-66-00 Myelofibrosis 5
A phase 3 study of orelabrutinib in combination with rituximab plus bendamustine (BR) compared with BR in subjects with treatment-naїve mant… Pending

2025-524241-27-00 Treatment-naїve mantle cell lymphoma (MCL) 5
A Phase 3 Study of DZD8586 versus Investigator’s Choice in r/r CLL/SLL Recruiting

2025-522669-32-00 Relapsed/Refractory Chronic Lymphocytic Leukemia/Small 5 2025-12-18
A study to test how well an oral medication called rilzabrutinib works and how safe it is for adults with immune thrombocytopenia (ITP) who … Recruiting

2025-522070-36-00 immune thrombocytopenia (ITP) 5 2025-12-15
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor (BTKi) and a Bcell Lymphoma-2 Inhibit… Recruiting

2025-521088-10-00 Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia 4 2025-10-23
A Study to Investigate the Safety and Efficacy of Pirtobrutinib in Adults with Immune Thrombocytopenia Recruiting

2024-518502-40-00 Immune Thrombocytopenia 9 2025-07-28
A Study to Assess Livmoniplimab in Combination with Budigalimab Versus Chemotherapy in Adult Participants with Metastatic Urothelial Carcino… Recruiting

2024-515506-11-00 Urothelial Carcinoma 4 2025-03-24
A Phase 1, dose determining study of EXS73565 in participants with relapsed or refractory B‑cell malignancies. Recruiting

2024-516869-36-00 Relapsed or refractory B-cell malignancies: chronic lym 1 2025-02-17
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants with Advanced Hematologic Maligna… Recruiting

2024-511457-22-00 Advanced Hematologic Malignancies 3 2025-01-30
A trial to learn if odronextamab is safe and well-tolerated and how well it works compared to rituximab combined with different types of che… Recruiting

2022-502660-20-00 Follicular lymphoma 5 2024-01-23
This study is to find out the safety and effectiveness of Epcoritamab together with R-CHOP (rituximab, cyclophosphamide, doxorubicin HCL, vi… Recruiting

2023-505277-32-00 Diffuse Large B-Cell Lymphoma (DLBCL) 5 2023-01-26
An unblinded, multi-center study evaluating long-term treatment with Zanubrutinib (BGB-3111) regimens in patients with blood cancer in the l… Recruiting

2024-511267-28-00 B-cell malignancies 5 2021-02-17
A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in… Recruiting

2025-525127-27-00 Generalized Myasthenia Gravis 9 2026-06-08
A phase 3 trial comparing elritercept versus epoetin alfa for treatment of anemia due to lower-risk MDS in ESA-naïve adults who require RBC … Recruiting

2025-523544-12-00 Myelodysplastic neoplasms/syndromes (MDS) 5 2026-06-02
A clinical study of belzutifan and zanzalintinib in people with advanced kidney cancer (MK-6482-034) Recruiting

2024-516993-31-00 Renal Cell Carcinoma 5 2026-05-11
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosi… Recruiting

2025-521546-23-00 Secondary progressive multiple sclerosis 5 2026-04-21
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight (RESTRAIN-SUI) Recruiting

2025-522514-23-00 Urinary Incontinence 5 2026-02-12
Randomized Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carc… Recruiting

2024-515023-11-00 Advanced Clear Cell Renal Cell Carcinoma 5 2026-01-22
A clinical study of belzutifan and zanzalintinib in people with advanced kidney cancer (MK-6482-033) Recruiting

2024-517136-21-00 Renal Cell Carcinoma 5 2025-12-05